Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial. por Musiime, V, Kendall, L, Bakeera-Kitaka, S, Snowden, W, Odongo, F, Thomason, M, Musoke, P, Adkison, K, Burger, D, Mugyenyi, P, Kekitiinwa, A, Gibb, D, Walker, A